4. Innovators Report: Key Takeaways
• Banner Year
• Big Deals
• Seed stage investments remain strong
• Triangle continues to dominate
• Continued interest from out of state investors
• Role of Non-VCs
14. Equity Funding by Deal Size
There were more large deals completed in 2015, with nineteen (19)
deals over $15 million – compared to five (5) deals in 2013 and six (6)
deals of that size in 2014.
Strong 1H 2015
Graph showing growth of 1H 2015 over 1H 2014 and 1H 2013
Conclusion: trend is very positive
At this rate we could top $1bilion for the year
Strong 1H 2015
Graph showing growth of 1H 2015 over 1H 2014 and 1H 2013
Conclusion: trend is very positive
At this rate we could top $1bilion for the year
Graphic showing last 8 qrts for tech vs last 8 quarters for Life science
Conclusion: Q2 2014 was anomaly for tech (Dude). Life science looked down last year but has had 5 quarter son the upswing
Q3 2015 anomaly with Avid Exchange $225 million but even with that taken out Qtr would have been up $84,227,576
Q4 2015
Between Series A and Series B funding, the average deal size increased by 300%. From Series B to Follow-on, the average deal size increased just 50%. Again, this is because of big Life Science deals in Series B.
75% of the state’s funding is in the Triangle. Note, $225M of the $270M in Charlotte is one deal – AvidXchange.
Where the investments are coming from by stage. Darker shaded states have most investments: NC, CA, NY. (note as you scroll through) Activity in the Midwest.
Where the investments are coming from by stage. Darker shaded states have most investments: NC, CA, NY. (note as you scroll through) Activity in the Midwest.
Where the investments are coming from by stage. Darker shaded states have most investments: NC, CA, NY. (note as you scroll through) Activity in the Midwest.
Where the investments are coming from by stage. Darker shaded states have most investments: NC, CA, NY.
These maps show institutional investors, but do not include a large number of undisclosed investors.